POSA48 Economic Evaluation of Extending the Danish Age-Based Pneumococcal Polysaccharide Vaccination Programme to Include Individuals Aged 50-54 and 55-59
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.193
https://www.valueinhealthjournal.com/article/S1098-3015(21)01988-4/fulltext
Section Title :
Section Order :
10965
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01988-4&doi=10.1016/j.jval.2021.11.193